No products in the cart.
Startseite » Poloxamer
Abstract Cancer remains to be one of the most life-threatening diseases with high rates of mortality and morbidity. The major...
PRESS RELEASE 19. November 2025 - Croda International Plc (“Croda”), a global leader in specialty ingredients, today announced a strategic...
Abstract Formulation development of protein biopharmaceuticals has become increasingly challenging due to new modalities and higher target drug substance concentrations....
Abstract The liquid and solid formulations of self-nano-emulsifying drug delivery systems (SNEDDS) have garnered significant attention in the pharmaceutical field...
Abstract Background: Solid dispersions (SDs) of etodolac (ETD), a poorly water-soluble drug model, were developed to enhance its solubility and dissolution...
Abstract Tacrolimus (TAC), a calcineurin inhibitor used topically for T-cell-mediated skin diseases, faces challenges due to poor solubility and limited...
Abstract Oral administration is the best way to administer both traditional and novel drugs because it decreases patient non compliance...
Abstract The oral bioavailability and therapeutic efficacy of a compound are largely determined by its aqueous solubility and interfacial partitioning....
Abstract This study investigates the use of an octenylsuccinate-modified dendrimer-like biopolymer (OS-DLB) as a carrier matrix in the formulation of...
Abstract Psoriasis is a hereditary, autoimmune, chronic illness that influences the immune system and can have both cutaneous and systemic...
Copyright: PharmaExcipients AG